RxSight Vs. Nukkleus Industry Stock Comparison

Sell

15

RXST
RxSight

Last Price:

$24.74

Seasonality Move:

36.37%

Sell

30

NUKK
Nukkleus

Last Price:

$13.81

Seasonality Move:

2.35%

Sell

15

RxSight (RXST) is a Sell

Is RxSight a Buy, Sell or Hold?

The current RxSight [RXST] share price is $25.10. The Score for RXST is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
RXST is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

30

Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

The current Nukkleus [NUKK] share price is $15.24. The Score for NUKK is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
NUKK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXST Stock Price Chart

What is RxSight's stock price today?

The RxSight share price today is $25.10

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXST is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

The Nukkleus share price today is $15.24

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUKK is experiencing buying pressure, which is a positive indicator for future bullish movement.

RXST Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.94	Sell
Relative Strength Index (14 RSI):	19.44	Sell
Chaikin Money Flow:	-448896	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(27.66 - 33.16)	Sell
Bollinger Bands (100):	(30.78 - 47.1)	Sell

NUKK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.84	Sell
Relative Strength Index (14 RSI):	45.19	Sell
Chaikin Money Flow:	185477	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(13.46 - 21.84)	Sell
Bollinger Bands (100):	(0.6 - 26.74)	Buy

RXST Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	27.07	Sell
20-day SMA:	29.58	Sell
50-day SMA:	31.74	Sell
200-day SMA:	46.13	Sell
8-day EMA:	26.94	Sell
20-day EMA:	28.94	Sell
50-day EMA:	32.41	Sell
200-day EMA:	41.2	Sell

NUKK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	15.14	Buy
20-day SMA:	16.05	Sell
50-day SMA:	23.11	Sell
200-day SMA:	8.59	Buy
8-day EMA:	15.16	Buy
20-day EMA:	16.6	Sell
50-day EMA:	17.82	Sell
200-day EMA:	15.69	Sell

RxSight Earnings Growth & RXST Earnings Dates

Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.04 per share, and an increase next year of $0.36 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

RxSight Technical Analysis

	Feb 21	Feb 25	Feb 26	Feb 27	Feb 28	Mar 3	Mar 4	Mar 5	Mar 6	Mar 7
	Feb						Mar
	21	25	26	27	28	03	04	05	06	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

	Feb 21	Feb 25	Feb 26	Feb 27	Feb 28	Mar 3	Mar 4	Mar 5	Mar 6	Mar 7
	Feb						Mar
	21	25	26	27	28	03	04	05	06	07
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):